Genomic characteristics and drug screening among organoids derived from non‐small cell lung cancer patients

BACKGROUND: Patient‐derived organoid (PDO) models are highly valuable and have potentially widespread clinical applications. However, limited information is available regarding organoid models of non‐small cell lung cancer (NSCLC). This study aimed to characterize the consistency between primary tum...

Full description

Saved in:
Bibliographic Details
Published in:Thorac Cancer
Main Authors: Chen, Jing‐Hua, Chu, Xiang‐Peng, Zhang, Jia‐Tao, Nie, Qiang, Tang, Wen‐Fang, Su, Jian, Yan, Hong‐Hong, Zheng, Hong‐Ping, Chen, Ze‐Xin, Chen, Xin, Song, Meng‐Meng, Yi, Xin, Li, Pan‐Song, Guan, Yan‐Fang, Li, Gang, Deng, Chu‐Xia, Rosell, Rafael, Wu, Yi‐Long, Zhong, Wen‐Zhao
Format: Artigo
Language:Inglês
Published: John Wiley & Sons Australia, Ltd 2020
Subjects:
Original Articles
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7396373/
https://ncbi.nlm.nih.gov/pubmed/32633046
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1759-7714.13542
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items